Search

everythinglearnresearchcommunity

for

Search:↓

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Type I interferons play a key role in the development of various skin diseases.

New hair and skin changes were found in a rare case of syphilis-related hair loss.

Vitamin D3 can help improve hair growth by enhancing the function of specific skin cells and could be useful in hair regeneration treatments.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

Fully regenerating human hair follicles not yet achieved.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Wnt3a activates certain genes in hair follicle cells, including a newly discovered one, EP2, which may affect hair growth.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Skin cells can help create early hair-like structures in lab cultures.

Immune cells affect hair growth and could lead to new hair loss treatments.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Hair transplants can effectively treat hair loss from CCCA in African American women if there's no inflammation.